CVS Health Corp. (CVS) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-09 (expected, before the open). EPS estimate 1.08, revenue estimate 107.78B.
Over the last 12 reports the stock moved 6.8% on average (either way), rising 7 times and falling 5. EPS beat estimates 10 of 12 times; revenue 10 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | 2.09 | 1.65 | +26.7% | 108.40B | 104.72B | -11.0% |
| Q2 FY2026 | 2026-08-05 | 2.58 | 1.85 | +39.5% | 106.10B | 100.03B | -7.9% |
| Q1 FY2026 | 2026-05-06 | 2.57 | 2.18 | +17.9% | 100.43B | 94.99B | +8.3% |
| Q4 FY2025 | 2026-02-10 | 1.09 | 1.00 | +9.0% | 105.69B | 103.70B | +1.6% |
| Q3 FY2025 | 2025-10-29 | 1.60 | 1.37 | +16.8% | 102.87B | 98.81B | -6.7% |
| Q2 FY2025 | 2025-07-31 | 1.81 | 1.46 | +24.0% | 98.92B | 94.53B | +0.3% |
| Q1 FY2025 | 2025-05-01 | 2.25 | 1.70 | +32.4% | 94.59B | 93.68B | +1.1% |
| Q4 FY2024 | 2025-02-12 | 1.19 | 0.91 | +30.2% | 97.71B | 97.09B | +20.7% |